248 related articles for article (PubMed ID: 11457825)
1. mu-Opioid receptor-mediated ERK activation involves calmodulin-dependent epidermal growth factor receptor transactivation.
Belcheva MM; Szùcs M; Wang D; Sadee W; Coscia CJ
J Biol Chem; 2001 Sep; 276(36):33847-53. PubMed ID: 11457825
[TBL] [Abstract][Full Text] [Related]
2. Mu opioid transactivation and down-regulation of the epidermal growth factor receptor in astrocytes: implications for mitogen-activated protein kinase signaling.
Belcheva MM; Tan Y; Heaton VM; Clark AL; Coscia CJ
Mol Pharmacol; 2003 Dec; 64(6):1391-401. PubMed ID: 14645669
[TBL] [Abstract][Full Text] [Related]
3. The fibroblast growth factor receptor is at the site of convergence between mu-opioid receptor and growth factor signaling pathways in rat C6 glioma cells.
Belcheva MM; Haas PD; Tan Y; Heaton VM; Coscia CJ
J Pharmacol Exp Ther; 2002 Dec; 303(3):909-18. PubMed ID: 12438509
[TBL] [Abstract][Full Text] [Related]
4. Mu and kappa opioid receptors activate ERK/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes.
Belcheva MM; Clark AL; Haas PD; Serna JS; Hahn JW; Kiss A; Coscia CJ
J Biol Chem; 2005 Jul; 280(30):27662-9. PubMed ID: 15944153
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of EGF-induced ERK/MAP kinase-mediated astrocyte proliferation by mu opioids: integration of G protein and beta-arrestin 2-dependent pathways.
Miyatake M; Rubinstein TJ; McLennan GP; Belcheva MM; Coscia CJ
J Neurochem; 2009 Jul; 110(2):662-74. PubMed ID: 19457093
[TBL] [Abstract][Full Text] [Related]
6. Nuclear Ca2+/calmodulin translocation activated by mu-opioid (OP3) receptor.
Wang D; Tolbert LM; Carlson KW; Sadée W
J Neurochem; 2000 Apr; 74(4):1418-25. PubMed ID: 10737597
[TBL] [Abstract][Full Text] [Related]
7. Ligand-dependent spatiotemporal signaling profiles of the μ-opioid receptor are controlled by distinct protein-interaction networks.
Civciristov S; Huang C; Liu B; Marquez EA; Gondin AB; Schittenhelm RB; Ellisdon AM; Canals M; Halls ML
J Biol Chem; 2019 Nov; 294(44):16198-16213. PubMed ID: 31515267
[TBL] [Abstract][Full Text] [Related]
8. Modulation of extracellular signal-regulated kinase (ERK) by opioid and cannabinoid receptors that are expressed in the same cell.
Korzh A; Keren O; Gafni M; Bar-Josef H; Sarne Y
Brain Res; 2008 Jan; 1189():23-32. PubMed ID: 18068691
[TBL] [Abstract][Full Text] [Related]
9. Agonist-induced, G protein-dependent and -independent down-regulation of the mu opioid receptor. The receptor is a direct substrate for protein-tyrosine kinase.
Pak Y; O'Dowd BF; Wang JB; George SR
J Biol Chem; 1999 Sep; 274(39):27610-6. PubMed ID: 10488100
[TBL] [Abstract][Full Text] [Related]
10. Proximal events in signaling by plasma membrane estrogen receptors.
Razandi M; Pedram A; Park ST; Levin ER
J Biol Chem; 2003 Jan; 278(4):2701-12. PubMed ID: 12421825
[TBL] [Abstract][Full Text] [Related]
11. Role of calmodulin in the modulation of the MAPK signalling pathway and the transactivation of epidermal growth factor receptor mediated by PKC.
Tebar F; Lladó A; Enrich C
FEBS Lett; 2002 Apr; 517(1-3):206-10. PubMed ID: 12062438
[TBL] [Abstract][Full Text] [Related]
12. Carbachol-stimulated transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T(84) cells is mediated by intracellular Ca2+, PYK-2, and p60(src).
Keely SJ; Calandrella SO; Barrett KE
J Biol Chem; 2000 Apr; 275(17):12619-25. PubMed ID: 10777553
[TBL] [Abstract][Full Text] [Related]
13. Endogenous RGS protein action modulates mu-opioid signaling through Galphao. Effects on adenylyl cyclase, extracellular signal-regulated kinases, and intracellular calcium pathways.
Clark MJ; Harrison C; Zhong H; Neubig RR; Traynor JR
J Biol Chem; 2003 Mar; 278(11):9418-25. PubMed ID: 12524446
[TBL] [Abstract][Full Text] [Related]
14. Pasteurella multocida toxin stimulates mitogen-activated protein kinase via G(q/11)-dependent transactivation of the epidermal growth factor receptor.
Seo B; Choy EW; Maudsley S; Miller WE; Wilson BA; Luttrell LM
J Biol Chem; 2000 Jan; 275(3):2239-45. PubMed ID: 10636931
[TBL] [Abstract][Full Text] [Related]
15. Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer.
Fujioka N; Nguyen J; Chen C; Li Y; Pasrija T; Niehans G; Johnson KN; Gupta V; Kratzke RA; Gupta K
Anesth Analg; 2011 Dec; 113(6):1353-64. PubMed ID: 22003224
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation of the mu-opioid receptor regulates agonist intrinsic efficacy.
McLaughlin JP; Chavkin C
Mol Pharmacol; 2001 Jun; 59(6):1360-8. PubMed ID: 11353794
[TBL] [Abstract][Full Text] [Related]
17. Roles of Src and epidermal growth factor receptor transactivation in transient and sustained ERK1/2 responses to gonadotropin-releasing hormone receptor activation.
Shah BH; Farshori MP; Jambusaria A; Catt KJ
J Biol Chem; 2003 May; 278(21):19118-26. PubMed ID: 12642580
[TBL] [Abstract][Full Text] [Related]
18. Delta opioid activation of the mitogen-activated protein kinase cascade does not require transphosphorylation of receptor tyrosine kinases.
Kramer HK; Onoprishvili I; Andria ML; Hanna K; Sheinkman K; Haddad LB; Simon EJ
BMC Pharmacol; 2002; 2():5. PubMed ID: 11897012
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon.
Piiper A; Elez R; You SJ; Kronenberger B; Loitsch S; Roche S; Zeuzem S
J Biol Chem; 2003 Feb; 278(9):7065-72. PubMed ID: 12496267
[TBL] [Abstract][Full Text] [Related]
20. Calmodulin binding to G protein-coupling domain of opioid receptors.
Wang D; Sadée W; Quillan JM
J Biol Chem; 1999 Jul; 274(31):22081-8. PubMed ID: 10419536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
